FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068698 [Registered on: 11/06/2024] Trial Registered Prospectively
Last Modified On: 03/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Other (Specify) [NACT with chemotherapy]  
Study Design  Single Arm Study 
Public Title of Study   Role of chemotherapy along with radiation in advanced carcinoma of cervix after induction chemotherapy in rural india  
Scientific Title of Study   A pilot study assessing the role of induction chemotherapy followed by chemo radiation in locally advanced cervical cancer in a tertiary care hospital in central rural India 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kanchan Dasharthrao Devde 
Designation  Senior Resident  
Affiliation  Datta Meghe Institute of higher education and research centre  
Address  Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha
Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha
Wardha
MAHARASHTRA
442001
India 
Phone  8788760080  
Fax    
Email  drkanchandevde@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amol Dongre 
Designation  Professor and Head of Department  
Affiliation  Datta Meghe Institute of higher education and research centre  
Address  Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha
Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha
Wardha
MAHARASHTRA
442001
India 
Phone  9322978781  
Fax    
Email  amolpgi@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Kanchan Dasharthrao Devde 
Designation  Senior Resident  
Affiliation  Datta Meghe Institute of higher education and research centre  
Address  Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha
Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha
Wardha
MAHARASHTRA
442001
India 
Phone  8788760080  
Fax    
Email  drkanchandevde@gmail.com  
 
Source of Monetary or Material Support  
Kanchan Devde Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha India Pin code 442001 
 
Primary Sponsor  
Name  Siddharth gupta memorial hospital 
Address  Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha India pin code 442001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kanchan Devde  Jawaharlal Neharu Medical College  Room no 101 Department of Medical Oncology Siddhartha Gupta Memorial JNMC AVBRH DMIMS Sawangi Meghe Wardha India pin code 442001
Wardha
MAHARASHTRA 
8788760080

drkanchandevde@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of higher education  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C539||Malignant neoplasm of cervix uteri, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Neoadjuvent chemotherapy with inj paclitaxel and inj carboplatin  Patients with stage III and IV procceds bt giving NACT with chemotherapy drug regimen injection paclitaxel 80mg per meter aquare and inj carboplatin Area Under Curve 2 weekly for 6 cycle for 44 days after that patient will plan for chemoradiation with concurrent cisplatin 40 mg per meter square then response assessment total duration of 3 months 
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Female 
Details  Age more than 18 year
ECOG 0/1
Good renal, hepatic and CBC
Women with biopsy proven squamous, adeno or adenosquamous carcinoma
Stage III and IVA FIGO (2018)
 
 
ExclusionCriteria 
Details  Patients with early stage cancer stage I and II
metastaic disease at presentation autoimmune disease patient who not willing for study  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
progression free survival in FIGO stage III and IVa patient after giving NACT  progression free survival in FIGO stage IIIand IVa patient after giving NACT after 8week of completion of radiation  
 
Secondary Outcome  
Outcome  TimePoints 
progression free survival   At baseline 
radiation side effect compliance and tolerabilty  baseline 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="2" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

After approval from the Institutional Ethics Committee, A pilot study will be conducted in MEDICAL ONCOLOGY and RADIATION ONCOLOGY Department of SGMCH unit of  department of Acharya Vinoba Bhave rural Hospital (AVBRH), a tertiary care teaching hospital situated in the rural area of  Wardha District, Maharashtra, India.

At first contact with the patient, a detailed history and clinical evaluation of the patient shall be done. Clinical examination and a biopsy from the cervical lesion shall be taken and any previous treatment will be ascertained. 


 
Close